click below
click below
Normal Size Small Size show me how
MSK
MSK (Musculoskeletal)
| Generic | Brand | Pharmacologic Category | Common Indications | Key Side Effects | US Boxed Warnings | Other Notes |
|---|---|---|---|---|---|---|
| tizanidine (PO) | Zanaflex | Alpha2 agonist | Spasticity | drowsiness, hypotension, dizziness, xerostomia, weakness | ||
| hydroxychloroquine (PO) | Plaquenil | Aminoquinolone | RA, SLE, malaria | retinal toxicity, rash, diarrhea | use has been associated with cardiomyopathy, bone marrow suppression, and neuromuscular effects (i.e., myopathy, palsies, and progressive weakness) | |
| colchicine (PO) | Colcrys | Antigout agent | Gout | diarrhea, nausea, vomiting, bone marrow suppression, myopathy (including rhabdomyolysis) | ||
| diclofenac (topical)* | Voltaren Gel | NSAID | OA | pruritus, rash | ||
| celecoxib (PO) | Celebrex | NSAID, COX-2 selective | OA, RA, acute pain | diarrhea, dyspepsia, abdominal pain, flatulence, nausea | may increase the risk of serious (and potentially fatal) cardiovascular thrombotic events, MI, and stroke; may increase the risk for serious (and potentially fatal) gastrointestinal adverse events including ulceration, bleeding, and perforation | may reduce renal blood flow and compromise existing renal function (avoid in patients with renal disease, heart failure, and cirrhosis) |
| diclofenac (PO) | Voltaren | NSAID | OA, RA, acute pain | diarrhea, dyspepsia, abdominal pain, flatulence, nausea | may increase the risk of serious (and potentially fatal) cardiovascular thrombotic events, MI, and stroke; may increase the risk for serious (and potentially fatal) gastrointestinal adverse events including ulceration, bleeding, and perforation | may reduce renal blood flow and compromise existing renal function (avoid in patients with renal disease, heart failure, and cirrhosis) |
| ibuprofen (PO)* | Motrin, Advil | NSAID | OA, RA, acute pain | diarrhea, dyspepsia, abdominal pain, flatulence, nausea | may increase the risk of serious (and potentially fatal) cardiovascular thrombotic events, MI, and stroke; may increase the risk for serious (and potentially fatal) gastrointestinal adverse events including ulceration, bleeding, and perforation | may reduce renal blood flow and compromise existing renal function (avoid in patients with renal disease, heart failure, and cirrhosis) |
| meloxicam (PO) | Mobic | NSAID | OA, RA, acute pain | diarrhea, dyspepsia, abdominal pain, flatulence, nausea | may increase the risk of serious (and potentially fatal) cardiovascular thrombotic events, MI, and stroke; may increase the risk for serious (and potentially fatal) gastrointestinal adverse events including ulceration, bleeding, and perforation | may reduce renal blood flow and compromise existing renal function (avoid in patients with renal disease, heart failure, and cirrhosis) |
| indomethacin (PO) | Indocin | NSAID | OA, RA, acute pain, gout | diarrhea, dyspepsia, abdominal pain, flatulence, nausea | may increase the risk of serious (and potentially fatal) cardiovascular thrombotic events, MI, and stroke; may increase the risk for serious (and potentially fatal) gastrointestinal adverse events including ulceration, bleeding, and perforation | may reduce renal blood flow and compromise existing renal function (avoid in patients with renal disease, heart failure, and cirrhosis) |
| naproxen (PO)* | Naprosyn, Anaprox, Aleve | NSAID | OA, RA, acute pain, gout | diarrhea, dyspepsia, abdominal pain, flatulence, nausea | may increase the risk of serious (and potentially fatal) cardiovascular thrombotic events, MI, and stroke; may increase the risk for serious (and potentially fatal) gastrointestinal adverse events including ulceration, bleeding, and perforation | may reduce renal blood flow and compromise existing renal function (avoid in patients with renal disease, heart failure, and cirrhosis) |
| ketorolac (PO, IV) | Toradol | NSAID | Pain (indicated for short term use (≤ 5 days)) | diarrhea, dyspepsia, abdominal pain, flatulence, nausea | may increase the risk of serious (and potentially fatal) cardiovascular thrombotic events, MI, and stroke; may increase the risk for serious (and potentially fatal) gastrointestinal adverse events including ulceration, bleeding, and perforation | may reduce renal blood flow and compromise existing renal function (avoid in patients with renal disease, heart failure, and cirrhosis) |
| cyclobenzaprine (PO) | Flexeril, Amrix, Fexmid | Skeletal muscle relaxant | Muscle spasm | drowsiness, dizziness, xerostomia, fatigue | use may cause prolonged cardiac arrhythmias, and tachycardia; CI within 14 days of MAOI inhibitor therapy | |
| methocarbamol (PO) | Robaxin | Skeletal muscle relaxant | Muscle spasm | drowsiness | ||
| baclofen (PO) | --- | Skeletal muscle relaxant | Spasticity | drowsiness | ||
| lidocaine (transdermal*, IV) | Transdermal: Lidoderm, IV: Xylocaine | Transdermal: topical analgesic IV: antiarrhythmic | Transdermal: pain IV: ventricular arrhythmias | Transdermal: dermatitis, erythema, urticaria, skin depigmentation, skin edema IV: bradycardia | patch may remain in place for up to 12 hours in any 24-hour period, patch may be cut | |
| allopurinol (PO) | Zyloprim | Xanthine oxidase Inhibitor | Gout | diarrhea, nausea, rash, leukopenia, thrombocytopenia | rare association with severe (and potentially fatal) allopurinol hypersensitivity syndrome (risk highest in certain Asian populations) | |
| succinylcholine (IV) | Anectine | Depolarizing neuromuscular blocking agent | Neuromuscular blockade for intubation or procedures | hyperkalemia, myalgia, malignant hyperthermia (rare) | acute rhabdomyolysis and hyperkalemia leading to cardiac arrest and death in pediatric patients with undiagnosed skeletal muscle disease | |
| etanercept (SQ) | Enbrel | Anti-tumor necrosis factor alpha inhibitor | RA | infection, injection site reaction, headache, nausea | serious infections, malignancies such as lymphoma | |
| adalimumab (SQ) | Humira | Anti-tumor necrosis factor alpha inhibitor | RA, Crohn's Disease, Ulcerative Colitis | infection, injection site reaction, headache, nausea | serious infections, malignancies such as lymphoma |